Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd ( (AU:OCC) ) just unveiled an update.
Orthocell Ltd has lodged an application with the ASX for quotation of additional ordinary fully paid shares, identified under ticker OCC. The filing details the issuance of 445,696 new shares on 5 May 2026, arising from the exercise or conversion of existing options or other convertible securities, modestly increasing the company’s quoted capital base.
The new share quotation represents a routine capital markets action that marginally dilutes existing shareholders while potentially strengthening Orthocell’s balance sheet, depending on the exercise terms of the underlying securities. The move signals ongoing engagement with equity funding mechanisms and maintains the company’s compliance and presence in the Australian public markets.
The most recent analyst rating on (AU:OCC) stock is a Buy with a A$1.24 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd is an Australian-listed company trading on the ASX under the code OCC. The announcement identifies the entity and its corporate details but does not specify its industry, products, or services in the provided text.
Average Trading Volume: 410,417
Technical Sentiment Signal: Hold
Current Market Cap: A$244.2M
See more insights into OCC stock on TipRanks’ Stock Analysis page.